Please join The George Washington University School of Public Health and Health Services (GW) for a live webinar to discuss a new report representing consensus findings from a cross-section of stakeholders that could help transform the process used to evaluate interventions to treat obesity.
The GW consensus report, “Obesity Drug Outcome Measures,” outlines a series of new approaches the stakeholder group of consumer advocates, obesity experts, researchers and providers found that should be considered by the U.S. Food and Drug Administration when evaluating the benefits and risks of obesity drugs.
Stakeholder group representatives, including experts in public health, patient advocacy, medical research, obesity medicine and academia, will participate in a national webinar to review the group’s roundtable discussion and report outcomes.
• Christine Ferguson, J.D., Director, Rhode Island Health Exchange; Professor, GW School of Public Health and Health Services – Moderator
• Scott Kahan, M.D., M.P.H., GW faculty member, obesity clinician – Presenter
• Neil Gesundheit, M.D., Professor of Endocrinology, Stanford University – Panelist
• Joseph Nadglowski, Jr., President/Chief Executive Officer, Obesity Action Coalition – Panelist
• Jeff Levi, Ph.D., Executive Director, Trust for America’s Health – Panelist
• Donna Ryan, M.D., Associate Executive Director for Clinical Research, Pennington Biomedical Research Center – Panelist
When: Tuesday, August 14, 2012, 12:00-1:30 p.m. EST
To register or for more information, please visit